Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.35 |
| ▸ | DRD2 | P14416 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CRHBP | P24387 | 1/20 | 0.34 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.34 |
| ▸ | XDH | P47989 | 1/20 | 0.34 |
| ▸ | UTS2R | Q9UKP6 | 2/20 | 0.33 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23913811 | 0.89 | ALDH1A1 (0.40) | HRH3SLC6A4ABCB1DRD2KDM4E | |
| SCHEMBL23914107 | 0.88 | HRH3 (0.40) | HRH3SLC6A4ABCB1DRD2CRHBP | |
| SCHEMBL23914453 | 0.88 | HRH3 (0.42) | HRH3SLC6A4DRD2KDM4EALDH1A1 | |
| SCHEMBL23913990 | 0.86 | HRH3 (0.41) | HRH3SLC6A4DRD2KDM4EALDH1A1 | |
| SCHEMBL23913812 | 0.79 | SLC6A4 (0.48) | HRH3SLC6A4KDM4EALDH1A1LMNA | |
| SCHEMBL23914326 | 0.73 | MEN1 (0.45) | ABCB1ALDH1A1LMNA | |
| SCHEMBL23914273 | 0.70 | CHRNA7 (0.42) | HRH3SLC6A4DRD2KDM4E | |
| SCHEMBL23914302 | 0.66 | ALDH1A1 (0.40) | SLC6A4KDM4EALDH1A1LMNAMAPK1 | |
| SCHEMBL23914303 | 0.66 | ALDH1A1 (0.40) | SLC6A4KDM4EALDH1A1LMNAMAPK1 | |
| SCHEMBL3090416 | 0.66 | ABCB1 (0.48) | HRH3SLC6A4ABCB1DRD2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | HRH3 4496/4885SLC6A4 4444/4885ABCB1 1555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.